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Abstract HIV-associated damage to the central nervous
system results in cognitive and motor deficits. Anti-retro-
viral therapies reduce the severity of symptoms, yet the
proportion of patients affected has remained the same or
increased. Although approximately half of HIV-infected
patients worldwide are women, the question of whether
biological sex influences outcomes of HIV infection has
received little attention. We explored this question for both
behavioral and cellular/morphologic endpoints, using a
transgenic mouse that inducibly expresses HIV-1 Tat in the
brain. After 3 months of HIV-1 Tat exposure, both sexes
showed similar reduced open field ambulation. Male Tat?
mice also showed reduced forelimb grip strength and
enhanced anxiety in a light–dark box assay. Tat? males did
not improve over 12 weeks of repeated rotarod testing,
indicating a motor memory deficit. Male mice also had
more cellular deficits in the striatum. Neither sex showed a
change in volume or total neuron numbers. Both had
equally reduced oligodendroglial populations and equiva-
lent microglial increases. However, astrogliosis and mi-
croglial nitrosative stress were higher in males. Dendrites
on medium spiny neurons in male Tat? mice had fewer
spines, and levels of excitatory and inhibitory pre- and
post-synaptic proteins were disrupted. Our results predict
sex as a determinant of HIV effects in brain. Increased
behavioral deficits in males correlated with glial activation
and synaptic damage, both of which are implicated in
cognitive/motor impairments in patients. Tat produced by
residually infected cells despite antiretroviral therapy may
be an important determinant of the synaptodendritic
instability and behavioral deficits accompanying chronic
infection.
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Introduction
Combination antiretroviral therapy (cART) has caused a
dramatic decline in human immunodeficiency virus (HIV)-
associated dementia and mortality. However, the overall
prevalence of more moderate motor and cognitive deficits,
collectively termed HIV-associated neurocognitive disor-
ders (HAND), has remained similar in cART treated
patients (Robertson et al. 2007; McArthur et al. 2010;
Heaton et al. 2011). In resource-limited countries, where
estimates are that only 36 % of the HIV-positive popula-
tion receives cART, the severity and/or prevalence of
neurocognitive disorders is higher (Nakasujja et al. 2005;
Wong et al. 2007; Joint United Nations Programme on
HIV/AIDS 2010a; Heaton et al. 2010; Tozzi et al. 2005).
HAND occurs even in aviremic, cART-treated individuals,
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suggesting that many anti-retroviral regimens fail to
reverse neurological damage, even while lengthening sur-
vival (Heaton et al. 2010, 2011; McArthur et al. 2010).
Approximately half of the 40 million persons infected with
HIV-1 worldwide are women (Joint United Nations Pro-
gramme on HIV/AIDS 2010a). The incidence of HIV is
higher in men compared with women in all ethnic groups in
the US (Joint United Nations Programme on HIV/AIDS
2010b; Centers for Disease Control and Prevention 2009) and
Europe (European Centre for Disease Prevention and Control/
WHO Regional Office for Europe 2011), and most studies on
HAND epidemiology in western countries focus on males.
Studies both pre- and post-cART have reported no difference
in rate of HIV-associated neurocognitive complications
between sexes in the United States (Robertson et al. 2004;
Bouwman et al. 1998). In other studies, the pre- and post-
cART risk of similar complications in both developed and
resource-limited regions was reportedly higher in females
(Wojna et al. 2006; Chiesi et al. 1996; Gupta et al. 2007;
Hestad et al. 2012). In contrast, Joska (Joska et al. 2011) found
the male genotype to be associated with HIV-related cogni-
tive dysfunction, and Liu (Liu et al. 1996) reported that male
HIV? injection drug abusers had higher cognitive impairment
rates. A recent survey of HIV status among patients in the
National Epidemiological Survey on Alcohol and Related
Conditions found HIV? males but not HIV? females had
higher rates of mood, anxiety, and personality disorders than
their same-sex HIV- counterparts, even when adjusted for
socio-demographic factors (Lopes et al. 2012). Disparities
between the sexes in health care services and access to HIV
treatment may be confounds, as globally, HIV-infected
women are more likely to live in poverty, and have lower
literacy levels, higher injection drug abuse rates, and poorer
mental health. These considerations might significantly
influence either CNS vulnerability to HIV, or a diagnosis of
neurocognitive disability (Basso and Bornstein 2000; Farin-
pour et al. 2003; Maki and Martin-Thormeyer 2009).
We utilized a mouse model with conditional expression
of HIV-1 Tat1–86 in the CNS to test whether biological sex
can influence HIV-related motor and cognitive outcomes.
Intriguingly, males showed more impairment in motor,
learning, and anxiety tests. Since multiple brain regions are
undoubtedly involved in such varied deficits, we specifi-
cally examined striatum, which is clearly impacted by HIV
and is also involved as a coordinating center in multiple
motor, memory, and motivational/emotional tasks and
behaviors. At a cellular level, Tat induction significantly
altered non-neuronal populations in both sexes. Impor-
tantly, males had greater increases in astroglia and acti-
vated microglia, and increased TUNEL? neurons.
Dendritic spine density was decreased more significantly in
Tat? males, and both inhibitory and excitatory pre- and
post-synaptic proteins were more significantly altered.
The substantial changes in synaptic organization
observed in male mice after chronic HIV-1 Tat exposure
may make males more vulnerable to motor and social/
cognitive behavioral impairment. We propose that HIV-1
Tat differentially affects aspects of inflammation and glial
reactivity/remodeling in males and females and that these
factors may underlie sex differences in synaptic reorgani-
zation and behavioral impairment in Tat transgenic mice,
and perhaps also in neuroAIDS patients.
Materials and methods
Animal studies were approved by the Institutional Animal
Care and Use Committee at Virginia Commonwealth
University.
Animals
Doxycycline (DOX)-inducible HIV-1IIIB Tat1–86 transgenic
mice were generated as described (Hauser et al. 2009;
Fitting et al. 2010b, 2013; Bruce-Keller et al. 2008). Since
tat transgene activity is controlled by the glial fibrillary
acidic protein (GFAP) promoter, Tat protein expression in
the CNS is limited to astroglia. All mice were genotyped to
confirm the presence of tat and rtTA transgenes. Chronic
CNS Tat expression was induced by feeding chow con-
taining DOX (Harlan Laboratories, Inc., Indianapolis, IN;
6 g/kg) to mice starting at 3 months of age for a 12-week
period. Control Tat- mice were also fed DOX-chow to
control for off-target drug effects. In some behavior studies
(grip strength, open field test, light/dark box test), other
mice of the same age and genotype received normal chow
through the experimental period so that data could be
normalized. All mice were fed ad libitum. Mice were
habituated to the study room for 60 min before all behavior
tests. GFAP transcription is sensitive to levels of many
hormones and growth factors, yet basal levels of GFAP
transcription using such promoters were reported to be
roughly similar in males and females in several studies
(Cordeau et al. 2008; Cho et al. 2009; Lundkvist et al.
1999). Doxycycline pharmacokinetics in males and
females are also similar (Binh et al. 2009).
Rotarod assay
An accelerating rotarod assay was used to evaluate motor
performance/coordination and motor memory (Shiotsuki
et al. 2010; Brooks and Dunnett 2009; Liu et al. 2010;
Jones and Roberts 1968), which are adversely affected in
HAND (Tozzi et al. 2005; Goodkin et al. 1997; Simioni
et al. 2010). All mice were naı¨ve to the apparatus until the
first test day. The Rotamex-5 treadmill (Columbus
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Instruments, Columbus, OH) consists of a rubber-surfaced,
3.0-cm diameter cylindrical treadmill connected to a
computer-controlled stepper motor-driven drum. For each
trial, mice were placed in individual compartments; the rod
was gradually accelerated from 1 to 40 rpm, in 1 rpm
increases per 15 s. Acceleration continued until 40 rpm
was reached or the animal fell from the rod. Falls were
detected by sensors at the bottom of each compartment.
Rotarod testing began after 1 week DOX treatment, and
was performed once per week for 4 weeks (13–16 weeks
of age). After a 4-week break, testing was resumed during
the third month of DOX treatment (21–24 weeks of age).
Forelimb grip strength test
Forelimb grip strength was measured as a second indication
of potential motor deficits (Chatillon DFE II grip strength
meter, Ametek Test and Calibration Instruments, Largo,
FL). Mice were held near the tail base and lowered toward
the apparatus until the bar was gripped firmly with both
forepaws. The mouse was then gently, but steadily, pulled
away from the bar until both forepaws released. Peak force
disturbance was automatically registered in grams-force
(gf). Each mouse was tested five times in quick succession;
the strongest measurement was taken as the score (reviewed
by Crabbe et al. 2003). Grip strength was normalized by
body weight (g) for statistical comparison.
Open-field and light/dark box testing
Open field and light/dark box tests are based upon the rodent’s
innate conflict between an aversion to exposed spaces and
tendency to explore novel environments (Wallace et al. 2008;
Cryan and Holmes 2005). The open field test measures
changes in overall locomotion and may indicate states such as
depression/anxiety that reduce willingness to explore. The test
apparatus is a box (30 9 30 9 15 cm) divided into nine
squares (Med Associates Inc., St. Albans, VT), enclosed in a
larger, sound-attenuating box equipped with overhead light-
ing and ventilation. In the open-field test, a mouse naı¨ve to the
test apparatus was placed at its center and habituated for
1 min. Activity over 10 min was then monitored by 16
infrared beam sensors along the X–Y plane (Ramezani et al.
2011; Burger et al. 2005). In the light–dark box adaptation
(Crawley and Goodwin 1980; Malmberg-Aiello et al. 2002),
the test apparatus described above is separated into two equal
compartments by a partition with an opening in the middle; a
black plastic roof covers one compartment. Anxious animals
tend to avoid exposure by spending more time in the dark
(Bourin and Hascoet 2003). Each mouse was placed in the
center of the lighted area (facing the darkened area) and
allowed to explore the novel environment for 10 min. Activity
was monitored as in the open field test. The number of squares
crossed in both light and dark regions was recorded for
10 min. For both tests, data from 6-month-old mice that
received 12 weeks of DOX treatment were normalized by
scores from control age-matched groups fed normal chow.
Stereology
Mice were deeply anesthetized with isoflurane (Baxter,
Deerfield, IL, USA) prior to perfusion with 4 % parafor-
maldehyde (pH 7.4, Sigma-Aldrich Co., St. Louis, MO) in
phosphate-buffered saline (PBS). After perfusion, brains
were immediately removed and post-fixed in fresh fixative
overnight, hemisected, rinsed several times, and left over-
night in 15 ml of PBS. The left brain halves were coronally
sectioned at 50 lm and stored individually in cryoprotec-
tant [30 % sucrose (w/v), 1 % polyvinylpyrrolidone (v/v),
30 % ethylene glycol (v/v) in 0.05 M phosphate buffer, pH
7.2, all from Sigma] at -20 C until use. Free-floating
sections containing the striatum were stained with Hoescht
33342 (1 lg/1 ml, 8 min, Molecular Probes Inc., Eugene,
OR) for all unbiased stereological estimation. Sections were
thoroughly rinsed and then mounted on gelatin-coated Su-
perFrost Plus slides (VWR Scientific, West Chester, PA) in
ProLong Gold anti-fade reagent (Life Technologies, Grand
Island, NY, USA), and then air-dried for C8 h in the dark.
The total number of (Hoescht?) cells in the striatum was
estimated using the optical fractionator method (West et al.
1991); the Cavalieri principle was applied to measure stri-
atal volume with assistance from a computerized stereology
system (Stereologer, Stereology Resource Center, Chester,
MD) (Mouton 2002). Every fifth section was selected from
the total sections through the striatum and analyzed to
estimate total cell number and striatal volume. Each refer-
ence space was outlined at low power (59), and cells were
counted using 1009 magnification under oil-immersion. A
guard volume of 2.0 lm was used during cell counting to
avoid sectioning artifacts, including lost caps and uneven
section surfaces. The slides were viewed on a Zeiss Axio-
Observer system with integrated Sony 3CCD Exwave HAD
camera system (Carl Zeiss, Inc., Thornwood, NY).
Immunohistochemistry and quantification
Perfusion and preparation of tissue sections were per-
formed as described for stereology. 10 lm frozen or 50 lm
free-floating sections were permeabilized with 0.2 % Tri-
ton X-100 in phosphate-buffered saline containing 1 %
bovine serum albumin (Sigma-Aldrich) for 30 min. To
assess proportional numbers of specific cells in the striata,
single- or double-label immunostaining was performed.
Primary antibodies specific for neuron-specific enolase
(NSE; 1:100, Abcam, Cambridge, MA), neuron nuclei
(NeuN; 1:200, Millipore, Temecula, CA), oligodendrocyte
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transcription factor 2 (Olig2; 1:100, Immuno-Biological
Laboratories, Minneapolis, MN), aldehyde dehydrogenase
family 1 member L1 (ALDH1L1; 1:500, Abcam), ionized
calcium binding adaptor molecule 1 (Iba-1; 1:200, Wako,
Osaka, Japan), and 3-nitrotyrosine (3-NT, 1:100, Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) were applied to
sections. For double immunostaining, individual primary
antibodies were sequentially applied and incubated over-
night at 4 C in a humidified chamber, followed by host-
matched fluorescent-conjugated secondary antibodies (1 h,
room temperature; Life Technologies). Immunostained
sections were then incubated with Hoechst 33342 dye
(1 lg/ml, 8 min; Life Technologies) to identify nuclei,
rinsed thoroughly, mounted in ProLong Gold anti-fade
reagent (Life Technologies), and then air-dried for C8 h in
the dark. To verify the proportion of neurons, oligoden-
drocytes, astrocytes and microglia in the striata, 300–350
Hoechst? cells were selected randomly per striatum and
assessed for NSE, Olig2, ALDH1L1, and Iba-1 expression,
respectively (n = 5–7). To determine the relative activa-
tion state of microglia, an independent group of 200 Iba-1?
cells were randomly selected per striatum and assessed for
3-NT expression. Striata were examined under oil immer-
sion at 1009 using a Zeiss AxioObserver system with
integrated MRm camera system.
Striatal neuron death
Neuron death was assessed by labeling for terminal
deoxynucleotidyl transferase-mediated UTP nick end-
labeling (TUNEL) followed by NeuN and Hoechst stain-
ing. A monoclonal antibody to NeuN and Hoechst 33342
(Life Technologies) were applied to 10 lm frozen coronal
sections that included the striatum from all DOX treated
groups as described above. TUNEL detection of in situ
DNA fragmentation was performed in accordance with
procedures in the In Situ Cell Death Detection Kit, TMR
red (Roche Applied Science, Indianapolis, IN) in the same
slides. To quantify active neuron death, the proportion of
cells that were both TUNEL? and NeuN? was determined
by counting at least 200 NeuN? cells in adjacent fields in
two different sections per animal (n = 6), at 639 magni-
fication. To determine neuron death, 200 NeuN? cells were
randomly selected for assessment of TUNEL (n = 6).
Immunoblotting
In vivo astrocytic markers and pre-/postsynaptic vesicle-
associated proteins were examined by immunoblotting in
striatal samples from all DOX treated groups (n = 6).
Striata were freshly harvested and homogenized (T-PER
Reagent, Thermo Scientific, Pittsburgh, PA), including a
protease inhibitor cocktail (Roche Applied Science).
Homogenized tissue lysates were centrifuged and then
stored at -80 C until use. Protein concentration of each
sample was measured using the BCA protein assay (Pierce,
Rockford, IL). 20 lg of lysates were loaded per well onto
4–20 % Tris–HCl Ready Gels (Bio-Rad Laboratories,
Hercules, CA), and Precision Plus Protein Dual Color
Standards (Bio-Rad; MW range 10–250 kDa) were used to
visualize protein transfer and determine molecular weight.
Proteins were transferred to PVDF membranes (Bio-Rad).
Antibodies to astrocyte (ALDH1L1, 1:1000, Abcam;
GFAP, 1:1000, Millipore) and pre-/postsynaptic [synapto-
tagmin 2 (Syt2), 1:100, Zebrafish International Resource
Center; synapsin (Syn), 1:1,000, Synaptic Systems; geph-
yrin (Geph), 1:1,000, Synaptic Systems,; post synaptic
density protein 95 (PSD-95), 1:3,000, Affinity BioRe-
agents] were used to probe the blots. Anti-GAPDH
(1:2,500, Abcam) was used to normalize protein loading.
Host-matched IRDye Infrared Dyes-conjugated second-
ary antibodies (LI-COR Biotechnology, Lincoln,
Nebraska) were applied to visualize each protein band.
Protein bands were detected on an Odyssey Infrared
Imaging System and intensity was analyzed by Odyssey
2.0 software (LI-COR).
Morphology of striatal cells
Medium spiny neuron morphology was also assessed in
tissues impregnated using a Golgi–Kopsch procedure
(Hauser et al. 2009; Fitting et al. 2010b). Briefly, brain
tissues were separately prepared from all groups after
10–16 weeks DOX administration (n = 6). Dendrites were
assessed in tissues subjected to a modified Golgi–Kopsch
procedure that impregnates cell processes of random neu-
rons and glia in their entirety (Hauser et al. 1989, 2009).
After 4 % paraformaldehyde perfusion as described above,
whole forebrains were isolated and immersed in 2 %
potassium dichromate and 5 % glutaraldehyde (v/v) in the
dark at room temperature, and silver-impregnated as pre-
viously published (Fitting et al. 2010b, 2013). The ratio of
dichromate solution to tissue volume was C50:1. After
6 days, tissues were gently washed in ultrapure water
(3 9 1 min), tissues were gently blotted to remove exces-
sive dichromate solution, and placed in aqueous 0.75 %
silver nitrate for 5 days in the dark (50:1 fluid to tissue
volume ratio). Intact forebrains were serial-sectioned on a
vibrating microtome (Leica VT1200S, Leica Biosystems,
Nussloch, Germany) at 110 lm in the coronal plane,
dehydrated through graded ethanols, cleared in xylene, and
mounted in Permount (Fisher Scientific, Waltham, MA).
Wooden tools were used in all tissue handling. Several
criteria were used to select dendrites for quantification: (1)
the cell must be fully impregnated throughout its entirety
(partially/incompletely impregnated cells were not
608 Brain Struct Funct (2015) 220:605–623
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assessed); (2) the dendrite must be parallel to the plane of
the section, as tilted/angled dendrites can foreshorten the
dendrite and influence density; (3) the dendrite must be
distinct from dendrites on other neurons. Dendrites were
considered pathologic when they were either stunted or
extremely thin, or had spines that were unevenly distrib-
uted or stunted (Fig. 7A, E, F) (Fitting et al. 2010b; Ferr-
ante et al. 1991; McNeill et al. 1988). The density of Golgi-
impregnated spines was assessed on third order dendrites (3
dendrites per neuron; 6 neurons per mouse; n = 6 mice). In
some neurons in male mice (but not females), all of the den-
drites had gross decreases in spine density (B5 spines per
10 mM) that were obvious even without counting (Fig. 7F).
We purposely left these grossly abnormal neurons out of the
measurements of average spine density so as not to unduly
bias the results. Instead, those neurons were included in the
counts of cells with pathologic dendrites (Fig. 7A).
Electron microscopy
Male transgenic mice exposed to Tat for 2.5 months
(n = 3) were perfused with 2 % paraformaldehyde/2 %
glutaraldehyde in phosphate buffer (pH 7.4, Sigma-Aldrich
Co.), and then post-fixed in 1 % osmium tetroxide (OsO4)
for 1 h. For dehydration, the fixed tissues were processed
through graded ethanols and infiltrated overnight in EMbed
812 (EMS, Hatfield, PA). Tissue was embedded in EMbed
812 and polymerized at 60 C for 1–2 days. Thin sections
of 600–700 A˚ thickness were cut on a Leica EM UC6i
ultramicrotome (Leica Microsystems), collected onto
formvar-coated grids, and stained with 5 % uranyl acetate
and Reynolds’s lead citrate (Reynolds 1963). Sections were
observed with a JEOL JEM-1230 TEM (JEOL USA, Inc.)
at 2,000–12,0009 magnification and images were obtained
using a Gatan Ultrascan 4000 digital camera (Gatan Inc.,
Pleasanton, CA) with DigitalMicrographTM software (Ga-
tan Inc.).
Statistical analysis
Analyses were done by one way, or main effect analysis of
variance (ANOVA) followed by Duncan’s post hoc testing,
and t test using Statistica 6.0 software (Statistica, Tulsa,
OK). Student’s t-test analyses were performed using
GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA).
Results
Accelerating rotarod assay
Mice exposed to DOX for 12 weeks performed an accel-
erating rotarod test once/week during weeks 1–4 and 9–12.
All groups except for male Tat? mice increased the dura-
tion of time spent on the rotarod over the 12 week period
(Fig. 1A). Tat? males remained on the bar for an average of
\200 s at all times. Female and male Tat- mice showed
longer running times versus the initial trial at all times after
Fig. 1 Chronic Tat expression in transgenic mice revealed a sex
difference in Tat effects on motor acquisition and grip strength.
Groups of Tat- and Tat? mice of both sexes were fed chow
containing DOX to induce Tat expression continuously for 3 month
in vivo. A Accelerating rotarod. All groups showed similar perfor-
mance during weeks 1–4 of DOX exposure. By week 9 and thereafter,
Tat- mice of both sexes remained on the rotarod for a significantly
longer time than at week 1. Female Tat? mice showed a similar
improvement by week 11. In contrast to all other groups, the
performance of male Tat? mice never differed from week 1. Thus,
while Tat exposure affected rotarod performance in both sexes, there
appeared to be a Tat-sex interaction on either task acquisition or
motor ability that was specific to males (*p \ 0.05 versus same mice
at week 1, one-way ANOVA, Duncan post hoc test, n = 6–8). B Grip
strength. Forelimb grip strength was tested in Tat- and Tat? mice of
both sexes with/without DOX treatment. After 12 weeks, there was
no difference due to sex or genotype among the groups fed normal
chow. However, chronic exposure to HIV-1 Tat caused significantly
decreased forelimb grip strength in the male Tat? group compared
with all others. Furthermore, male Tat? mice were the only group
affected by chronic Tat induction (§p \ 0.05; **p \ 0.01, male Tat?
versus all other groups with DOX, one-way ANOVA, Duncan post
hoc test, n = 6–8)
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week 4, reaching a maximum mean of 350 s. Female Tat?
mice reached a similar maximum running time but required
more time to improve from their initial performance. There
was also a significant difference between groups for the
highest rotation speed reached before falling, which was
14 rpm for male Tat? mice, and 21–24 rpm for all other
groups (p \ 0.05, one-way ANOVA, Duncan’s post hoc
test, n = 6–8, data not shown).
Forelimb grip strength
Forelimb grip strength was assessed in Tat? and Tat- mice
fed DOX-containing chow for 12 weeks and in additional
groups matched for age, sex, and genotype fed normal
chow. Groups receiving normal chow showed no differ-
ence in forelimb grip strength after normalizing for body
weight. DOX did not influence grip strength in females
regardless of transgene expression (Fig. 1B), and Tat-
males receiving DOX had values equivalent to females.
Forelimb strength was significantly reduced in male Tat?
mice receiving DOX (Fig. 1B), who showed the weakest
grip strength among all groups receiving DOX .
Open-field and light/dark box test
Open-field exploration of a novel environment was evaluated
in Tat? and Tat- mice fed DOX-containing chow for
12 weeks and compared with age, sex, and genotype-matched
groups fed normal chow. Total distance traveled in 10 min
was significantly reduced in both male and female Tat? mice
after chronic Tat induction (Fig. 2A; Supplemental
Table 1A), with no additional effect of biological sex.
A standard light/dark box test was performed to test
whether HIV-1 Tat exposure induced anxiety-related
behavior in a sex-dependent manner. Ambulation in the
dark was similar for female Tat- and Tat? mice, and male
Tat- mice. However, male Tat? mice had significantly
higher ambulation in the dark compared with all other
groups, suggesting an increase in anxiety-like behavior due
to chronic HIV-1 Tat expression (Fig. 2B, C; Supplemental
Table 1B).
Stereological analysis of striatum cell number
and volume
The striatal sections examined were centered on the mid-
caudate/putamen area, at approximately Section 25 in a
mouse stereotaxic atlas (Franklin and Paxinos 1997).
Unbiased stereological estimation of Hoechst-stained cells
showed more total cells in the striatum of female than male
mice irrespective of Tat expression (Fig. 3A), although
there was no significant difference in the estimated striatal
volume of any group (Fig. 3B).
Effects of chronic Tat induction on total and TUNEL?
neuron populations in striata
Two neuron markers were used to assess the effect of
chronic Tat induction on the striatal neuron population.
Small increases in TUNEL reactivity were measured in
both female and male Tat? mice in NeuN? and NSE? (not
shown) striatal neurons (Fig. 4A). Although the differences
were significant, these TUNEL?/NeuN? cells represented
B3 % of all NeuN? cells. The proportion of total cells
(Hoechst?) that were NSE? neurons was unaffected in
either sex (Fig. 4B). NSE was used to assess total neurons,
since immunostaining in these relatively thick sections was
more consistent than with NeuN antibodies.
Effects of chronic Tat induction on oligodendrocyte
populations in striata
We examined the population of cells expressing the tran-
scription factor Olig2 after 12 weeks of DOX treatment.
Olig2 is a transcription factor expressed in oligodendro-
cytes at all developmental stages (Woodruff et al. 2001;
Ligon et al. 2006). HIV-1 Tat induction significantly
decreased populations of Olig2? oligodendroglia in Tat?
females and Tat? males with no significant differences due
to sex (Fig. 4C). Double-labeling for Olig2 and the mature
oligodendrocyte marker CC1/APC shows that [90 % of
Olig2? cells are also CC-1/APC? (Fig. 4D).
Effects of chronic Tat induction on astrogliosis
To assess Tat-induced changes in the proportion of astro-
cytes in striatum, we used two reliable markers of astroglia,
GFAP and aldehyde dehydrogenase 1 family, member L1
(ALDH1L1), which may be a more reliable marker in
rodent brain (Yang et al. 2011; Cahoy et al. 2008). The
proportion of total (Hoechst?) striatal cells expressing
ALDH1L1 was increased for both Tat? males and females
after 12 weeks of DOX treatment. Additionally, there was
a sex effect since male Tat? mice had significantly more
ALDH1L1? cells compared with female Tat? mice
(Fig. 5A). After chronic Tat induction, the intensity of
ALDH1L1 bands in immunoblots from tissue lysates of
both female and male Tat? mice was increased (Fig. 5B).
Those from male Tat? mice were significantly enhanced
compared with all other groups (Fig. 5C), suggesting a sex-
related interaction on gliosis. GFAP band intensity in Tat?
groups was not significantly increased versus the Tat-
group of the corresponding sex, although Tat? male mice
did have higher GFAP levels than female mice of either
genotype. Overall, even considering the differences
between GFAP and ALDH1L1 results, male mice show
higher astrocyte activation than females (Fig. 5B-D).
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Effect of chronic Tat induction on reactive microglia
After 12 weeks DOX treatment, the percent of Iba-1?
cells among total striatal cells of female and male Tat-
mice was similar, and Tat induction caused comparable
increases in the proportion of Iba-1? cells (Fig. 6A).
3-NT, a product of tyrosine nitrosylation mediated by
reactive nitrogen species such as peroxynitrite (ONOO-)
and nitrogen dioxide (NO2), has been used as a marker of
nitrosative cellular stress (Ryu and McLarnon 2006;
Shavali et al. 2006; Shishehbor and Hazen 2004), par-
ticularly in activated microglia. Iba-1/3-NT co-localiza-
tion was assessed as a measure of microglial activation.
Tat induction significantly increased the proportion of
microglia expressing 3-NT in both sexes (Fig. 6B, C).
There was a significant interactive effect of sex since the
proportion of 3-NT? microglia was higher in male than in
female mice (Fig. 6B).
Effect of chronic Tat induction on spine density,
morphology, and synaptic proteins
Morphology
A significant increase of medium spiny neurons with
pathologic dendrites was observed in Tat? mice of both
sexes, with a slightly greater increase in males versus
females (Fig. 7A). This category includes stunted or
extremely thin dendrites or those having spines that were
unevenly distributed or stunted (Fig. 7E, F). It also
includes neurons in which all visible, third-order dendrites
had severe spine loss (density B5/10 lM; Fig. 7E, F).
Spine density
For each neuron examined, the density of spines was
measured on all visible third-order dendrites. Adult mice
Fig. 2 Long-term Tat exposure decreased ambulatory activity and
induced anxiogenic-like behavior. Open-field and light/dark box tests
were applied to Tat- and Tat? mice of both sexes at 6 months of age,
after 12 weeks of normal or DOX-supplemented chow. Data for each
DOX-treated group are presented as the percent of ambulatory
activity normalized to the matched group receiving normal chow.
A Open field test. Long-term Tat induction reduced ambulatory
activity in both sexes (**p \ 0.01; ***p \ 0.001, one-way ANOVA,
Duncan’s post hoc test, n = 6–8). There was no significant difference
between female and male Tat- or Tat? mice. B Light/dark box test.
Long-term Tat exposure selectively induced anxiogenic-like effects in
the male Tat? group compared to all other groups (*p \ 0.05, one-
way ANOVA, Duncan’s post hoc test, n = 6–8). C Representative
diagrams of light/dark box test results. Tat? males showed signifi-
cantly increased ambulation in the dark side of the test compartment
compared to all other groups
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normally exhibit spine densities of approximately 15 per
10 lM in such dendrites (Cheng et al. 1997). In 2–5 % of
neurons in Tat? mice, all visible dendrites had a spine density
of less than 5 per 10 lM (Fig. 7F); this level of pathology,
which was obvious even without counting, was never seen in
Tat- mice. To obtain a more accurate assessment of spine
density in the seemingly normal dendrites, neurons with these
extremely spine deficiencies were not included in the calcu-
lation of average spine densities. Even exclusive of the
severely aberrant neurons, average spine density was
decreased in Tat? mice. There were significantly fewer spines
in males regardless of genotype (Fig. 7B, C).
Synaptic proteins
Changes in spine density are likely to affect synaptic
organization and function; thus we performed immunoblot
analysis to determine if Tat induction affected the stability
of either pre- or post-synaptic inhibitory (Syt2, gephyrin)
and excitatory (Syn, PSD-95) synaptic proteins. Tat
induction altered levels of both inhibitory synaptic proteins,
but only in brains of male mice, where Syt2 was increased and
gephyrin was reduced (Fig. 8A–C). The excitatory presyn-
aptic Syn protein was decreased in both sexes of Tat? mice; as
observed for other parameters including spine density, males
were significantly more affected (Fig. 8A, D). Excitatory
postsynaptic PSD-95 levels were specifically reduced in Tat?
males (Fig. 8A, E).
Striatal ultrastructure
Qualitative electron microscopic evaluation revealed sev-
eral structural anomalies in Tat? male tissue (Fig. 9). Most
prominent were seemingly normal capillaries invested by
notably swollen astroglial cytoplasm. Expanded, watery
astroglial processes were conspicuous throughout an
otherwise normal appearing neuropil. The cytoarchitecture
of neuron cell bodies appeared largely normal, with per-
haps more frequent autophagic inclusions. Axonal damage
was noted, as were areas of axons with abnormally thin
myelin. Cellular ultrastructure in Tat- mice appeared
normal.
Fig. 3 Effects of long-term Tat induction on total number of striatal
cells and striatal volume. Brain sections including striata from Tat-
and Tat? mice of both sexes at 6 month age, after 12 weeks of DOX-
supplemented chow were utilized for stereological estimation of total
striatal cell number and striatal volume. A Unbiased stereological
estimates showed that total striatal cells (Hoechst?) were more
numerous in female as compared to male mice (*p \ 0.05, one-way
ANOVA, main effect, n = 3). However, there was no effect of
chronic Tat on total striatal cell number in either sex. B Striatal
volumes were similar in males and females; chronic Tat induction by
DOX administration did not alter the estimated striatal volume in
either sex (n = 3) Fig. 4 Effects of chronic Tat induction on neurons and NPCs in
striata. Brain sections including the striatal region from DOX-treated
Tat- and Tat? mice of both sexes were examined. A Chronic Tat
expression increased the proportion of NeuN? cells that were
TUNEL? in the striatum of both sexes (*p \ 0.05, **p \ 0.01,
one-way ANOVA, Duncan post hoc test, n = 6–7). Additionally,
male Tat? striata had a greater percentage of TUNEL?/NeuN? cells
than were observed in female Tat? striata. B The percent of NSE-
immunostained cells was unaffected by Tat. Since there were no
differences in striatal volume between the sexes, this suggests no
difference in total striatal neuron numbers at this time (n = 5).
C Chronic Tat induction also decreased the percent of cells
expressing Olig2 in the striatum. The Olig2? population was
decreased similarly in Tat? mice of both sexes (*p \ 0.05,
**p \ 0.01, one-way ANOVA, Duncan post hoc test, n = 6).
D The striatal cells were triple-labeled for Olig2? (green), CC-1/
APC? (red), and the nuclear stain Hoechst 33342 (blue). Fluorescent
imaging indicates that [90 % of Olig2? cells are also CC-1/APC?.
White arrow indicates an Olig2? cell that does not express CC-1/
APC. All other Olig2? cells in this figure are double-labeled
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Discussion
In the post-cART era, neuroAIDS has become a chronic
disease largely characterized by an increased prevalence of
milder cognitive and motor disorders (HAND) with less
encephalitis (Antinori et al. 2007; McArthur et al. 2010;
Sacktor et al. 2001; Gonzalez-Scarano and Martin-Garcia
2005; Woods et al. 2009; Ellis et al. 2007; Wojna et al.
2006; Dore et al. 2003; Lawrence and Major 2002; Grant
et al. 1995; Heaton et al. 1995). Although the subset of
female HIV patients has expanded, the question of whether
sex influences the occurrence and characteristics of neu-
rocognitive dysfunction in HIV? patients is largely
unexplored. Studies on HAND epidemiology in western
countries, where the disease is more prevalent in men,
focus largely on males. In more resource-limited settings,
social variables between the sexes that affect health care
access and quality make sex-related disease vulnerabilities
difficult to determine. A recent study suggests that overall
rates of neuropsychological impairment may not reflect the
entire picture; HIV? men and women may be differen-
tially impaired in certain attention/memory tasks yet show
a similar overall decline (Failde-Garrido et al. 2008).
Inducible Tat-transgenic mice are a reasonable model
for testing whether sex influences HAND development
since they exhibit many neuropathologic and behavioral
Fig. 5 Effects of chronic Tat induction on striatal astroglia.
A ALDH1L1 immunohistochemistry was performed on brain sections
from all groups after 12 weeks of DOX administration. Chronic Tat
exposure significantly increased the population of ALDH1L1? cells
in the striata of Tat? mice of both sexes. The effect of Tat was
significantly greater in Tat? males than in Tat? females (*p \ 0.05;
***p \ 0.001, one-way ANOVA, Duncan’s post hoc test, n = 6). B–
D Immunoblots were also performed with ALDH1L1 and GFAP
antibody after chronic Tat induction. Fresh striata were harvested and
dissected from DOX-treated Tat- and Tat? mice of both sexes.
B Shows representative blots for ALDH1L1, GFAP, and GAPDH.
C The intensity of ALDH1L1 bands was significantly increased in
tissue lysates from Tat? mice of both sexes. Blots from lysates of
male Tat? mice were significantly more intense than those of any
other group (*p \ 0.05 versus all other groups, one-way ANOVA,
Duncan’s post hoc test after normalization to GAPDH). The
difference between Tat? and Tat- females was only detectable using
a less stringent test (#\0.05, Student’s t test, one-tailed). Overall, male
Tat? lysates showed greater ALDH1L1 intensity than female Tat?
lysates after normalization (§p \ 0.05, one-way ANOVA, main
effect, n = 6). D The effects of Tat were less robust when GFAP
was examined, but there was a sex-related interaction. Tat- mice of
both sexes had equivalent, normalized GFAP expression. Chronic Tat
induction by DOX did not increase GFAP levels in either male or
female mice versus their Tat- controls. However, after 12 weeks of
DOX administration, the intensity of GFAP immunoblots in male
Tat? mice was greater than both Tat? and Tat- female mice
(*p \ 0.05, one-way ANOVA, Duncan’s post hoc test)
Brain Struct Funct (2015) 220:605–623 613
123
deficits seen in HIV patients with HAND, including gliosis
and microglial activation (Bruce-Keller et al. 2008), den-
dritic abnormalities and reduced dendritic spine density
(Fitting et al. 2010b, 2013; Hauser et al. 2009), disrupted
hippocampal circuitry, changes in synaptic proteins (Fitting
et al. 2013), and learning/behavioral deficits (Fitting et al.
2013; Carey et al. 2012). The transgenic line used here,
developed by Dr. Avi Nath, appears to exhibit less CNS
pathology than a similar line (Zou et al. 2007; Kim et al.
2003) and was chosen because the pathology has a slower
onset more representative of that in HIV patients. While
most in vivo studies have used HIV-1 Tat exposure times
of B2 weeks, we chose a 3-month exposure as potentially
more reflective of persistent human disease. In a variety of
well-characterized animal behavior tests, chronic Tat
exposure negatively affected motor, cognitive, and anxiety
measures, in general agreement with outcomes after more
acute exposure (Fitting et al. 2013; Carey et al. 2012,
2013), and mirroring cortical and subcortical functional
deficits in HIV patients that affect both cognitive and motor
skills (Woods et al. 2009; McArthur et al. 2010; Heaton
et al. 2010). Importantly, our results also provide initial
evidence of an underlying difference in male versus female
vulnerability. In all instances where severity differed
between sexes, Tat? male mice had poorer outcomes,
while Tat? females were similar to control/Tat- mice.
CNS tissue was evaluated to determine if cell popula-
tions were altered in a similar sex-specific manner, perhaps
accounting for sex-specific behavioral changes. Since
multiple brain regions are undoubtedly involved in these
quite varied behavior deficits, we specifically examined the
dorsal striatum, which is clearly impacted by HIV, and as
Fig. 6 Effects of chronic Tat induction on microglia in striatum.
A The proportion of striatal cells expressing Iba-1 was increased to
the same extent in both chronically induced male and female Tat?
groups compared with their respective Tat- controls (**p \ 0.01;
***p \ 0.001, Duncan’s post hoc test, n = 6–7). B Chronic HIV-1
Tat exposure also induced a significant increase in the production of
3-NT in Iba-1? cells of both sexes. Although there was no sex
difference in Tat effect on the Iba-1? population overall, 3-NT
expression within the Iba-1? population was significantly higher in
male Tat? mice than in female Tat? mice (*p \ 0.05; **p \ 0.01;
***p \ 0.001, Duncan’s post hoc test, n = 6–7). Thus, HIV-1 Tat
exposure appears to enhance microglial numbers equally in both
sexes, but to disproportionately enhance the production of nitrosylat-
ed species in microglia within male mice. C Fluorescence image of a
triple-labeled, Iba-1? (green)/3-NT? (red) microglial cell. Blue color
indicates Hoechst 33342 staining within the nuclei of this cell, and
nearby cells that are not Iba-1?. 3-NT immunostaining within the
scant microglial cytoplasm is indicated by the arrow. Note the
ramified appearance of the microglial cell, whose processes likely
branch out of the field of this 10-lM section. Microglia with a
ramified morphology are usually associated with lower levels of
activation, and it is interesting that even cells with this morphology
have detectable 3-NT
Fig. 7 Effects of chronic Tat induction on spine density and dendrite
morphology in striatal medium spiny neurons. A Each neuron was
categorized as having dendrites with an entirely normal morphology,
or having an abnormal morphology with one or more dendrites that
displayed aberrant morphology, such as uneven spine distributions,
low spine number (less than 5 in 10 lm), or stunted or extremely thin
dendrites. The proportion of neurons that possessed one or more
dendrites with abnormal morphology was counted and reported as a
percentage of total neurons examined (20 neurons per mouse, each
with C3 dendrites, 6 mice). Chronic Tat induction significantly
increased the percentage of neurons with morphological abnormalities
in both sexes. Male Tat? mice were significantly more affected,
suggesting a Tat-sex interaction (*p \ 0.05, ***p \ 0.001, one-way
ANOVA, Duncan’s post hoc test, n = 6). B, C Dendritic spines were
counted on third-order dendrites of medium spiny neurons. Density
was recorded as the mean number of spines per 10 lm dendrite
length, averaged for each animal (spines/10 lm) (n = 6 mice; 3
dendrites per neuron; 6 neurons per mouse). The baseline spine
density in Tat- mice showed a slight but significant sex-specific
difference, with lower density in males. Tat induction significantly
decreased total spine density in Tat? mice of both sexes as compared
with Tat- mice (*p \ 0.05, **p \ 0.01, ***p \ 0.001, one-way
ANOVA, Duncan’s post hoc test, n = 6). Scale bars 10 lm.
D Normal medium spiny neuron in striatum of Tat- male. E–
F Medium spiny neurons with abnormal morphologies in the striatum
of Tat? males. The cells in E have sparse spines that unevenly
distributed; the cell in F has extremely few spines, most of which are
very stunted. Cells like that shown in F, in which all dendrites were
abnormal, were only found in Tat? male mice and represented less than
5 % of all impregnated striatal neurons. This type of cell was never found
in other groups, including Tat? females. Insets in D through F show
higher magnification of areas indicated in larger figures
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the main input region for the basal ganglia is also involved
in coordinating multiple behaviors. While the striatum is
well known to control and modulate movements and tasks
involving motor memory, striatal integration is also a key
component in executive functions and decision making,
and in processing motivational and emotional information
relating to reward and anxiety (Voytek and Knight 2010;
Balleine et al. 2007; Helfinstein et al. 2012). Unbiased
stereological analyses indicated that Tat exposure did not
affect either striatal volume or total striatal cell number in
either sex. When individual populations of cells were
quantified, there were effects of both sex and Tat exposure
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(Figs. 4, 5). Tat expression increased the percentage of
apoptotic (TUNEL?) neurons, with slightly greater effect
on male brains. The increased neuron loss was not reflected
in total NSE? numbers. We interpret this to suggest that
neurons may only have started to die relatively recently,
which is in keeping with our finding that TUNEL? stria-
tal neurons were not increased after short-term Tat expo-
sure in these mice (Bruce-Keller et al. 2008). Over time, if
Fig. 8 Effects of chronic Tat induction on expression of pre- and
post-synaptic markers in striatum. A Striatal lysates were examined
by immunoblotting to quantify levels of protein pairs associated with
inhibitory (Syt2, gephyrin) and excitatory (Syn, PSD-95) pre- and
post-synaptic membranes, respectively. The intensity of all bands was
normalized to GAPDH. B, C Levels of inhibitory synaptic proteins
were only affected in male Tat? mice. Relative to most other groups,
presynaptic Syt2 was increased (*p \ 0.05, one-way ANOVA,
Duncan’s post hoc test, n = 6) and postsynaptic gephyrin (Geph)
was decreased (*p \ 0.05 versus all other groups, one-way ANOVA,
Duncan’s post hoc test, n = 6). D, E Both female and male Tat? mice
exhibited a decrease in the excitatory presynaptic protein synapsin 1
(Syn) compared with Tat- mice; levels in male Tat? mice were
significantly less than those in female Tat? mice. The excitatory
postsynaptic PSD-95 protein was reduced only in male Tat? mice,
compared with all other groups. (*p \ 0.05, **p \ 0.01, one-way
ANOVA, Duncan’s post hoc test, n = 6)
Fig. 9 Ultrastructure of the striatum after 3 months of Tat induction
in transgenic mice. Although much of the neuropil appears normal,
both glia and neurons exhibit multiple features that are atypical. A A
montage view shows the healthy-appearing nucleus and cytoplasm of
a medium spiny neuron (MSN), two capillaries (Cap), one of which
has an associated endothelial cell, and surrounding neuropil of normal
density. Axons all appear to have myelin of an appropriate thickness.
While the astrocyte (AS) has a seemingly normal nucleus with
nucleoplasm of homogeneous density and a relatively inconspicuous
nucleolus, the cytoplasm of the astrocyte is abnormally clear and
watery and does not contain the intermediate filaments that usually
distinguish this cell type. B Abnormal myelination in a group of
axons. In the normal adult CNS, myelinated axons of the same caliber
are invested with myelin sheaths that are very similar in thickness
within a given brain region. This ‘‘g-ratio’’ (axon diameter/fiber
diameter) is used to assess normal myelination. Note that while most
axons towards the left side of the field are appropriately myelinated,
many axons of equal caliber towards the right side have thin myelin.
The labels ‘‘a–c’’ indicate groups of axons of decreasing caliber with
myelin sheaths of relatively normal thickness; labels ‘‘a*–c*’’
indicate similar groups of axons that have much thinner myelin than
their counterparts in the ‘‘a–c’’ groups. The myelin is of good
compaction, indicating that if remyelination has occurred, the process
has not been recent. C A neuron (MSN) with normal nucleoplasm and
cytoplasm is found next to a capillary (Cap) that is invested with a
large amount of watery astroglial cytoplasm (AS). It is normal to have
astroglial endfeet enveloping a capillary, but this large volume of
swollen cytoplasm is not normal. Capillaries with similarly distended
astroglial endfeet are common in the tissue. D Two of the axons (Ax)
in this group show clear signs of degeneration. The integrity of the
axoplasm has been compromised, and there is also obvious shrinkage/
contraction of axoplasmic area. In comparison with adjacent normal
axons, very few neurofilaments can be distinguished within the
axoplasm, which is of an unusual, flocculent consistency. Asterisks
indicate regions where the axoplasm has retracted from the
surrounding myelin sheath. Degenerating axons are occasionally
seen within the normal CNS, but are more prominent in these tissues.
Arrow indicates an abnormal membrane structure discussed in F and
G. E A myelin sheath has improperly formed around two axons (Ax).
At higher magnification (not shown), the axons clearly are contained
within separate outer membranes. Arrows indicate abnormal mem-
branous bodies that are frequently seen in these axons (see F, G).
F This panel shows a higher magnification view of unusually watery
astroglial cytoplasm (AS), as well as two examples of abnormal
membrane structures that are frequently seen within axons from these
Tat? transgenic mice (arrows). These membrane bodies can reach
quite remarkable lengths (see G) and in some cases appear to be
multilamellar. They are quite different in structure from smooth
endoplamic reticulum, and at present their origin is undetermined.
They have not been observed in axons in the striatum or hippocampus
of Tat? transgenic mice after 7–10 days of DOX exposure (Fitting
et al. 2010b, 2013), nor are they observed in Tat- mice receiving
DOX for the same 3 month period (not shown). G An axon contains a
dense, ungranulated membranous structure of remarkable length
(double arrows) within otherwise normal-appearing axoplasm. This
membranous body appears to be multilamellar. The large amount of
oligodendroglial cytoplasm surrounding the axon is not necessarily
pathologic. A similar but smaller membranous structure is indicated
by an arrow in an adjacent axon. Bars in each panel indicate the
magnification
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a low rate of neuron death continues in the absence of
replacement, the neuron population will eventually be
reduced by a significant level . Tat expression also reduced
Olig2? oligodendroglia independent of sex, perhaps relat-
ing to reports that HIV-1 Tat reduces young oligodendro-
cyte proliferation in vitro (Hahn et al. 2012).
In the absence of neuron loss, what might account for
observed behavioral deficits? Since we only examined total
neurons, changes in subpopulations of striatal neurons
affecting behavior may have been overlooked. Another
possibility relates to changes in glial populations (Figs. 5,
6). Chronic exposure to Tat expanded the CNS population
of ALDH1L1? astroglia, as previously observed for
GFAP? astroglia after acute Tat exposure (Bruce-Keller
et al. 2008). Cell counts and immunoblots generally con-
curred that astroglial expansion/astrogliosis was greater in
males. As in more acute studies (Gupta et al. 2010; Hahn
et al. 2010; Fitting et al. 2010c; Suzuki et al. 2011; Bruce-
Keller et al. 2008), the microglial population also increased
after chronic Tat exposure. Both sexes showed equivalent
Iba-1? cell increases, but 3-NT, a nitrosative product
indicative of microglial activation, was specifically ele-
vated in males. Thus, both microglial activation and as-
trogliosis correlate with altered behavior in male Tat?
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brains. While not proving a causal relationship, the sus-
tained, low levels of inflammation described in HIV?
brains even after cART treatment do produce cumulative
deficits (Heaton et al. 2010, 2011; Cohen et al. 2010;
Gongvatana et al. 2013) and would predict this outcome.
Additionally, or alternatively, the relative deficits in male
behavior might derive from their more significant abnor-
malities in dendrite structure and levels of specific synaptic
proteins (Figs. 7, 8). Chronic Tat exposure reduced the
density of spines on striatal medium spiny neurons in both
sexes, similar to other reports with Tat, gp120 or HIV (Sa
et al. 2004; Fitting et al. 2010b; Viviani et al. 2006). The
pattern of loss was remarkably similar to spine changes
reported with cortical deafferentation (Cheng et al. 1997),
suggesting interruption of normal cortical connections that
account for over 80 % of striatal input. The fact that spine
loss recovers after a deafferentation injury (Cheng et al.
1997) may be a hopeful sign for the recovery potential of
HIV patients. Both spine loss and abnormal dendrite
pathology were clearly higher in male mice, which also
showed changes in proteins associated with both inhibitory
(presynaptic Syt2, postsynaptic gephyrin) and excitatory
(presynaptic synapsin, postsynaptic PSD95) synapses. In
females, only the excitatory presynaptic protein synapsin
was modestly reduced. While HIV exposure may reduce
synaptodendritic efficacy in general (Masliah et al. 1997;
Everall et al. 1999; Fitting et al. 2013), Tat interactions
may specifically affect how efficiently inhibitory versus
excitatory information is processed, at least in striatum
(Figs. 7, 8) and hippocampus (Fitting et al. 2013). Sex-
specific protein alterations may thus contribute to differ-
ences in behavioral outcomes. Notably, reversible changes
in excitatory synaptic proteins have been reported in vitro
(Shin and Thayer 2013; Shin et al. 2012). Changes in
synaptic efficiency likely occur before neuron loss, since
synaptic protein changes occurred in hippocampus after
more acute (10 days) Tat exposure (Fitting et al. 2013).
An extensive literature, both epidemiological and
experimental, suggests that males are more vulnerable to
trauma and neurodegenerative events/diseases (de Lau and
Breteler 2006; Van Den Eeden et al. 2003; Coronado et al.
2011; Mehal et al. 2013). The lower vulnerability of
females may be related to the documented neuroprotective
role of estrogen in trauma and neurodegenerative studies
(Yune et al. 2008; Rau et al. 2003; Roof and Hall 2000;
D’Astous et al. 2004; Hoffman et al. 2006; Tang et al.
1996), although recent work emphasizes that sex as an
injury variable includes more than single hormone-single
receptor interactions, and involves both genomic and non-
genomic effects (Cheng and Hurn 2010; Herson et al.
2009). Although a preponderance of evidence suggests that
some component of estrogen-mediated protection derives
from down-regulation of dopamine transporter function in
the striatum (Wallace et al. 2006; Disshon and Dluzen
1999; Murray et al. 2003), other mechanisms are likely
involved in striatum and elsewhere, including expression of
endogenous anti-oxidants such as paraoxonase 2 (Giordano
et al. 2013) and glutathione (Kumar et al. 2011), as well as
anti-oxidant enzyme systems (Kumar et al. 2011; Rao et al.
2011). Recent evidence also suggests that a component of
estrogen-mediated neuroprotection may be due to promo-
tion of adaptive responses within neurons, and that males
and females can respond differently to locally produced
steroids versus those produced or delivered systemically
(Gillies and McArthur 2010). Estrogens or ER-b signaling
has been shown to exert neuroprotective effects on several
HIV models including gp120 injection (Corasaniti et al.
2005), and in vitro Tat or gp120 exposure (Russo et al.
2005; Adams et al. 2010, 2012; Wallace et al. 2006;
Brooke et al. 1997) potentially by modulating the balance
of protective and inflammatory chemokine/cytokines
(Corasaniti et al. 2005; Kipp and Beyer 2009; Dhandapani
et al. 2005; Bruce-Keller et al. 2007), or reducing oxidative
changes in mitochondria (Simpkins et al. 2010). A cau-
tionary note for all HIV studies is the potential for sex
steroids, including progestins, to modulate infective pro-
cesses (Asin et al. 2008; Zhang et al. 2008; Hel et al. 2010;
Lee et al. 1997), which may complicate comparisons
between epidemiological and experimental studies.
In conclusion, the data support the hypothesis that chronic
exposure to HIV-1 Tat may play a significant role in the
decline of cognitive and motor function in HIV patients,
perhaps related to or driven by changes in specific cell pop-
ulations. This study has examined cellular changes specifi-
cally within the striatum, but the behavioral deficits observed
almost certainly will involve pathology in other CNS regions.
Sex appears to be an important variable in predicting vul-
nerability to behavioral deficits, with males being significantly
more affected in several standard rodent tests of motor and
social/cognitive skills. Males also showed an enhanced state
of glial activation and more evidence of synaptic damage, both
of which have been related to cognitive and motor impair-
ments in HIV patients. Importantly, Tat will be produced and
released by residually infected CNS cells even when new
infection is limited by cART (Johnson et al. 2013), suggesting
its importance in determining the stability of CNS cell pop-
ulations and motor and cognitive health during chronic
infection.
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